Better ways to handle tablets using IBCs

| May 30, 2019

article image
It is common to find Intermediate Bulk Containers (IBCs) being used for handling powders and granules in solid dosage manufacturing processes, from initial Dispensing through to Tablet Compression or Capsule Filling. The benefits of using IBCs for efficient and flexible materials handling at this stage of the process are widely appreciated and applied in modern facilities. However, when it comes to tablets, these are still traditionally handled in small containers such as drums, small kegs or boxes. In this article Shaun Baker, Pharmaceutical Sales Director for Matcon Limited, considers the benefits and challenges of handling tablets in larger volumes and using IBCs.

Spotlight

Aerobit Health Limited

There is a need for patients to remember to adhere with their treatments and keep doctors in the loop with critical data. Aerobit is platform of smart hardware and software making managing asthma easier and more effective than ever. Aerobit’s mission is to be at the epicenter of improving Asthma care through a revolution in digital healthcare. Aerobit is a digital health startup building an asthma care platform with a Smart Inhaler Device at the epicenter. Our aim is to improve the quality of life of millions of asthma sufferers in the UK and reduce the risk of unnecessary fatalities due to this common chronic disease.

OTHER ARTICLES

Comparing HydroxyChloroquine Trials

Article | April 1, 2020

One minor side effect of the pandemic is that perhaps more people will learn about what drug research and clinical trials can really be like. Today’s example: we have a clinical trial of hydroxychloroquine from Wuhan that has just published on a preprint server. What’s good is that this one is blinded, randomized, and controlled (like the earlier hydroxychloroquine which one I blogged about here from Zhejiang University, so we can actually talk about it rather than just spend all our time wondering what the heck is going on.

Read More

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | March 4, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

Tips for Managing Chronic Pain Beyond Prescription Painkillers

Article | February 17, 2020

Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to be highly addictive. In fact, it has even been reported that there are more cases of a drug overdose and deaths from prescription painkillers than heroin or cocaine. While there are a number of factors that play into this opioid epidemic, educating doctors and patients on alternative solutions to managing chronic pain is a great place to start combatting this nationwide crisis.

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 6, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

Spotlight

Aerobit Health Limited

There is a need for patients to remember to adhere with their treatments and keep doctors in the loop with critical data. Aerobit is platform of smart hardware and software making managing asthma easier and more effective than ever. Aerobit’s mission is to be at the epicenter of improving Asthma care through a revolution in digital healthcare. Aerobit is a digital health startup building an asthma care platform with a Smart Inhaler Device at the epicenter. Our aim is to improve the quality of life of millions of asthma sufferers in the UK and reduce the risk of unnecessary fatalities due to this common chronic disease.

Events